IMVT Immunovant, Inc.: Forvard P/S multiplikatori
Immunovant, Inc. (IMVT) laboratoriya energiya iste'molini optimallashtirish orqali immunologik dori vositalarini ishlab chiqishga ESG tamoyillarini joriy qilmoqda. Kompaniya hozirda maqsadli antitelolar portfelini kengaytirib, klinik sinovlarning yakuniy bosqichlarini tezlashtirmoqda. Kompaniyaning kutilayotgan P/S ko'rsatkichlari jadvali baholash dinamikasini aks ettiradi, bunda qiymati bazaviy ko'rsatkich bo'lib xizmat qiladi. Kelgusida, noyob patologiyalar uchun patentlangan davolash usullarining noyobligi emitentga sezilarli narx belgilash imkoniyatini taqdim etadi.
Immunovant Therapeutics (IMVT) kompaniyasi koʻrsatkichlari kesimi va tahlili
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- emitentning balans qiymati statistikasi:
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Umumiy qarzning xususiy kapitalga nisbati Immunovant, Inc.|IMVT - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Immunovant, Inc.|IMVT - Kompaniyaning jamlangan qarzi|Qarzning balans kapitallashuviga nisbati Immunovant Therapeutics|IMVT - Uzoq muddatli qarz|Kompaniyaning qisqa muddatli majburiyatlari Immunovant|Tezkor likvidlik koeffitsiyenti immunovant.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
IMVT - Sof foyda|Kutilayotgan foyda Immunovant, Inc.|IMVT - Narx-foyda multiplikatori|Prognoz qilingan narxning foydaga nisbati Immunovant Corp|IMVT - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti Immunovant Therapeutics|IMVT - Foizlar, soliqlar va amortizatsiya chegirilmasdan oldingi daromad|Bir aksiya uchun sof foyda (EPS TTM) Immunovant|IMVT - So'nggi to'rtta chorak uchun bir aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi immunovant.com|IMVT - Bu yil bir aksiya uchun foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi Immunovant, Inc.
- sotuvlar va tushum bo'yicha ma'lumotlar:
Kompaniyaning fundamental baholanishi:IMVT (Immunovant)
Forward P/S biznesning bozor qiymatini kutilayotgan savdo hajmi bilan nisbatda o'lchaydi, bu esa investorga aktivlarning haddan tashqari qiziganlik darajasini va adolatli baholash chegaralarini aniqlash imkonini beradi. Kam uchraydigan kasalliklar nishasida noyob antitelalarni ishlab chiquvchi Immunovant, Inc. (IMVT) uchun forward narx-savdo koeffitsiyenti bozor hozirda uning terapiyalarining kelgusidagi klinik samaradorligi va patent himoyasini qanchalik darajada baholayotganining ko'rsatkichi bo'lib xizmat qiladi.
Raqobatchilar tahlili
Forvard P/S multiplikatori ARGX (argenx)|BioNTech Inc. (BNTX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Abivax Corp - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati ADMA Corp ADMA|Protagonist Therapeutics (PTGX) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori kiniksa.com|Narxning prognoz qilingan daromadga nisbati Grifols|Forvard narx/daromad multiplikatori Adaptive Biotech (ADPT)|Forvard narx/daromad multiplikatori CLDX (Celldex)|Forvard P/S multiplikatori Aurinia Corp (AUPH)|Narxning prognoz qilingan daromadga nisbati BioCryst BCRX|VERA: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|DNTH - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Pharvaris NV|ABCL (AbCellera Biologics Inc) - Forvard narx/daromad multiplikatori|TRML (Tourmaline) - Narxning prognoz qilingan daromadga nisbati|PGEN (Precigen, Inc.) - Forvard P/S multiplikatori|Forvard P/S multiplikatori pharming.com|Narxning prognoz qilingan daromadga nisbati Nektar Therapeutics Inc. (NKTR)|Upstream Bio, Inc. - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|Zenas Biopharma, Inc. - Forvard narx/daromad multiplikatori|Narxning kutilayotgan daromadga nisbati IMNM (Immunome Bio)|GOSS: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx KALV (kalvista.com)|SEPN: Forvard P/S multiplikatori|PVLA - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Savara Corp|Kapitalizatsiyaning prognoz qilingan daromadga nisbati RIGL (Rigel Corp)|Forvard P/S multiplikatori ANAB|Forvard narx/daromad multiplikatori astriatx.com ATXS|enGene - Forvard narx/daromad multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati RAPT Therapeutics Inc. (RAPT)|Aerovate - Forvard P/S multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Aclaris Therapeutics, Inc ACRS|Kyverna Therapeutics (KYTX) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori tizianalifesciences.com|Forvard narx/daromad multiplikatori CABA|Narxning prognoz qilingan daromadga nisbati VTYX|Forvard narx/daromad multiplikatori THTX (Theratechnologies Inc)|Narxning kutilayotgan daromadga nisbati AVTX|Narxning prognoz qilingan daromadga nisbati Eledon Pharmaceuticals ELDN|AGEN (agenusbio.com) - Kelajakdagi narxning daromadga nisbati|Climb Bio - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx ZURA (Zura Bio Ltd)|ATYR: Forvard P/S multiplikatori|Adagene Inc. (ADAG) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati ImageneBio|STTK: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Equillium, Inc. (EQ)|Forvard narx/daromad multiplikatori connectbiopharm.com CNTB|Forvard P/S multiplikatori IMUX (Immunic)|Forvard P/S multiplikatori Atara Biotherapeutics, Inc. ATRA|IFRX: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx XFOR (x4pharma.com)|ACET: Forvard P/S multiplikatori|CELU - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati INmune Bio Corp|Forvard narx/daromad multiplikatori Barinthus Biotherapeutics Corp (BRNS)|Narxning prognoz qilingan daromadga nisbati Kezar Life Sciences (KZR)|Forvard narx/daromad multiplikatori sabbiotherapeutics.com SABS|Akari Therapeutics Plc - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori Enlivex Therapeutics Ltd ENLV|QTTB - Narxning prognoz qilingan daromadga nisbati|GOVX (GeoVax Corp) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|EDSA: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati ibioinc.com (IBIO)|CARM (Carisma Therapeutics Inc) - Forvard P/S multiplikatori|XTL Biopharmaceuticals Ltd (XTLB) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Bolt Biotherapeutics (BOLT)|Forvard narx/daromad multiplikatori hcwbiologics.com HCWB|Narxning prognoz qilingan daromadga nisbati Aptevo Therapeutics Inc. APVO|AIM - Forvard narx/daromad multiplikatori|ADTX: Forvard narx/daromad multiplikatori|GRI - Forvard P/S multiplikatori|XORTX (XRTX) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati HIND|Narxning prognoz qilingan daromadga nisbati Revelation Biosciences|Bozor kapitallashuvining kelajakdagi daromadga nisbati indaptusrx.com INDP|Forvard narx/daromad multiplikatori SCNI (Scinai Immunotherapeutics Ltd.)|Narxning prognoz qilingan daromadga nisbati CALI (calcimedica.com)|Forvard P/S multiplikatori AFMD (Affimed N.V.)|Forvard P/S multiplikatori Allakos Inc ALLK|HOOK - Narxning prognoz qilingan daromadga nisbati|IGMS (IGM Biosciences, Inc.) - Kapitalizatsiyaning prognoz qilingan daromadga nisbati|ITOS (iTeos Therapeutics, Inc.) - Forvard narx/daromad multiplikatori|OCEA: Narxning kutilayotgan daromadga nisbati|Forvard narx/daromad multiplikatori TCBP|THRD: Sotuvga nisbatan forvard narx
